Brachytherapy offers biochemical control at 10 years


Chicago-One of the first large studies to determine the 10-year efficacy of brachytherapy in men with prostate cancer shows that patients receiving a dose of at least 160 Gy have a 93% chance of being free of biochemical failure and a 95.4% chance of local control at 10 years.

Related Videos
3d rendered illustration of kidney cancer | Image Credit: © SciePro -
Bottle of white pills | Image Credit: © leighannef -
A panel of 5 experts on prostate cancer
A panel of 5 experts on prostate cancer
Illustration of AI | Image Credit: © Tierney -
DNA illustration | Image Credit: © -
Mara R. Holton, MD, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.